Markus Klinger

2.2k total citations
41 papers, 1.8k citations indexed

About

Markus Klinger is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Markus Klinger has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Markus Klinger's work include Aortic aneurysm repair treatments (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Markus Klinger is often cited by papers focused on Aortic aneurysm repair treatments (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Markus Klinger collaborates with scholars based in Austria, Poland and Denmark. Markus Klinger's co-authors include Michael Freissmuth, Christian Nanoff, Birgit Gruenberger, Thomas Gruenberger, Beata Herberger, Dietmar Tamandl, Markus G. Seidel, Stefan Hacker, Klaus Kaczirek and Christoph Höller and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Accounts of Chemical Research.

In The Last Decade

Markus Klinger

41 papers receiving 1.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Markus Klinger 616 523 376 348 327 41 1.8k
Yusuke Inoue 744 1.2× 686 1.3× 510 1.4× 172 0.5× 457 1.4× 148 2.2k
James L. Kinsella 1.9k 3.0× 387 0.7× 421 1.1× 380 1.1× 629 1.9× 44 3.1k
Yu Guo 1.1k 1.8× 423 0.8× 283 0.8× 151 0.4× 182 0.6× 91 2.3k
Yi‐Shuan Li 1.4k 2.4× 215 0.4× 339 0.9× 133 0.4× 524 1.6× 28 3.8k
Hua Wu 1.3k 2.1× 543 1.0× 263 0.7× 22 0.1× 229 0.7× 80 2.5k
Dechun Li 1.1k 1.7× 643 1.2× 530 1.4× 59 0.2× 381 1.2× 96 2.7k
Ken Kataoka 1.1k 1.8× 291 0.6× 133 0.4× 124 0.4× 255 0.8× 49 2.3k
Xi Cheng 816 1.3× 518 1.0× 266 0.7× 47 0.1× 190 0.6× 108 2.0k
Lin Zhong 578 0.9× 181 0.3× 120 0.3× 83 0.2× 267 0.8× 72 1.5k
Guoliang Wang 748 1.2× 353 0.7× 432 1.1× 93 0.3× 226 0.7× 149 2.0k

Countries citing papers authored by Markus Klinger

Since Specialization
Citations

This map shows the geographic impact of Markus Klinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Klinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Klinger more than expected).

Fields of papers citing papers by Markus Klinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Klinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Klinger. The network helps show where Markus Klinger may publish in the future.

Co-authorship network of co-authors of Markus Klinger

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Klinger. A scholar is included among the top collaborators of Markus Klinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Klinger. Markus Klinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jabłońska, Agnieszka, Edyta Paradowska, Christoph Neumayer, et al.. (2021). Abdominal aortic aneurysm and virus infection: A potential causative role for cytomegalovirus infection?. Journal of Medical Virology. 93(8). 5017–5024. 9 indexed citations
2.
Jabłońska, Agnieszka, Christoph Neumayer, Michael Bolliger, et al.. (2020). Insight into the expression of toll-like receptors 2 and 4 in patients with abdominal aortic aneurysm. Molecular Biology Reports. 47(4). 2685–2692. 6 indexed citations
3.
Jabłońska, Agnieszka, Christoph Neumayer, Markus Klinger, et al.. (2020). TLR2 2029C/T and TLR3 1377C/T and −7C/A Polymorphisms Are Associated with the Occurrence of Abdominal Aortic Aneurysm. The Journal of Immunology. 204(11). 2900–2909. 5 indexed citations
4.
Jabłońska, Agnieszka, Christoph Neumayer, Michael Bolliger, et al.. (2018). Analysis of host Toll-like receptor 3 and RIG-I-like receptor gene expression in patients with abdominal aortic aneurysm. Journal of Vascular Surgery. 68(6). 39S–46S. 13 indexed citations
5.
Eilenberg, Wolf, Stefan Stojković, Aleksandra Piechota-Polańczyk, et al.. (2016). Neutrophil Gelatinase-Associated Lipocalin (NGAL) is Associated with Symptomatic Carotid Atherosclerosis and Drives Pro-inflammatory State In Vitro. European Journal of Vascular and Endovascular Surgery. 51(5). 623–631. 83 indexed citations
6.
Klinger, Markus, et al.. (2015). Clinical Usefulness of a Novel Freehand 3D Imaging Device for Radio-Guided Intraoperative Sentinel Lymph Node Detection in Malignant Melanoma. Clinical Nuclear Medicine. 40(9). e436–e440. 14 indexed citations
7.
Piechota-Polańczyk, Aleksandra, Svitlana Demyanets, Ihor Huk, et al.. (2013). Decreased Tissue Levels of Cyclophilin A, a Cyclosporine A Target and Phospho-ERK1/2 in Simvastatin Patients with Abdominal Aortic Aneurysm. European Journal of Vascular and Endovascular Surgery. 45(6). 682–688. 25 indexed citations
8.
Tamandl, Dietmar, Markus Klinger, Beata Herberger, et al.. (2010). Sinusoidal Obstruction Syndrome Impairs Long-Term Outcome of Colorectal Liver Metastases Treated with Resection after Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 18(2). 421–430. 109 indexed citations
9.
Tamandl, Dietmar, Birgit Gruenberger, Markus Klinger, et al.. (2010). Liver Resection Remains a Safe Procedure After Neoadjuvant Chemotherapy Including Bevacizumab. Annals of Surgery. 252(1). 124–130. 36 indexed citations
10.
Klinger, Markus, Dietmar Tamandl, Stefan Hacker, et al.. (2010). Bevacizumab Improves Pathological Response of Colorectal Cancer Liver Metastases Treated with XELOX/FOLFOX. Annals of Surgical Oncology. 17(8). 2059–2065. 78 indexed citations
11.
Klinger, Markus, Stefan Hacker, Beata Herberger, et al.. (2009). Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases. European Journal of Surgical Oncology. 35(5). 515–520. 123 indexed citations
12.
Klinger, Markus, et al.. (2008). Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases. European Journal of Surgical Oncology. 34(11). 1231–1236. 64 indexed citations
13.
Tamandl, Dietmar, Beata Herberger, Birgit Gruenberger, et al.. (2008). Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 15(10). 2787–2794. 120 indexed citations
14.
Hetz, Hubert, Konrad Höetzenecker, Stefan Hacker, et al.. (2007). Caspase‐cleaved cytokeratin 18 and 20 S proteasome in liver degeneration. Journal of Clinical Laboratory Analysis. 21(5). 277–281. 21 indexed citations
15.
Farhan, Hesso, Christian Schuster, Markus Klinger, et al.. (2006). Inhibition of Xenograft Tumor Growth and Down-Regulation of ErbB Receptors by an Antibody Directed against Lewis Y Antigen. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1459–1466. 26 indexed citations
16.
Riemer, Angelika B., Markus Klinger, Stephan N. Wagner, et al.. (2004). Generation of Peptide Mimics of the Epitope Recognized by Trastuzumab on the Oncogenic Protein Her-2/neu. The Journal of Immunology. 173(1). 394–401. 83 indexed citations
17.
Klinger, Markus, Hesso Farhan, Herwig Just, et al.. (2004). Antibodies Directed against Lewis-Y Antigen Inhibit Signaling of Lewis-Y Modified ErbB Receptors. Cancer Research. 64(3). 1087–1093. 57 indexed citations
18.
Klinger, Markus, Oliver Kudlacek, Markus G. Seidel, Michael Freissmuth, & Veronika Sexl. (2002). MAP Kinase Stimulation by cAMP Does Not Require RAP1 but SRC Family Kinases. Journal of Biological Chemistry. 277(36). 32490–32497. 64 indexed citations
19.
Klinger, Markus, Herwig Just, Eduard Stefan, et al.. (2002). Removal of the carboxy terminus of the A 2A -adenosine receptor blunts constitutive activity: differential effect on cAMP accumulation and MAP kinase stimulation. Naunyn-Schmiedeberg s Archives of Pharmacology. 366(4). 287–298. 47 indexed citations
20.
Klinger, Markus, Michael Freissmuth, & Christian Nanoff. (2002). Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cellular Signalling. 14(2). 99–108. 228 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yusuke Inoue Breakdown of academic impact, for papers by James L. Kinsella Breakdown of academic impact, for papers by Yu Guo Breakdown of academic impact, for papers by Yi‐Shuan Li Breakdown of academic impact, for papers by Hua Wu Breakdown of academic impact, for papers by Dechun Li Breakdown of academic impact, for papers by Ken Kataoka Breakdown of academic impact, for papers by Xi Cheng Breakdown of academic impact, for papers by Lin Zhong Breakdown of academic impact, for papers by Guoliang Wang
Rankless by CCL
2026